VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q58883981 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010728.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q58883981‏
024 ‎‡a 0000-0002-8371-7597‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q58883981‏
100 0 ‎‡a Eve M.D. Smith‏ ‎‡c researcher ORCID ID = 0000-0002-8371-7597‏ ‎‡9 en‏
400 0 ‎‡a Eve M.D. Smith‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's Adding to complexity: comorbidity in paediatric rheumatic disease.‏
670 ‎‡a Author's An unusual cause of neonatal respiratory distress.‏
670 ‎‡a Author's Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups‏
670 ‎‡a Author's Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK‏
670 ‎‡a Author's Diagnosis and treatment of childhood-onset systemic lupus erythematosus (European evidence-based recommendations from the SHARE initiative)‏
670 ‎‡a Author's Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.‏
670 ‎‡a Author's Endothelial nitric oxide synthase polymorphisms do not influence pulmonary artery systolic pressure at altitude‏
670 ‎‡a Author's Fifteen-minute consultation: A structured approach to the management of hypermobility in a child.‏
670 ‎‡a Author's Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis‏
670 ‎‡a Author's Juvenile-onset systemic lupus erythematosus (jSLE) - Pathophysiological concepts and treatment options‏
670 ‎‡a Author's Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis‏
670 ‎‡a Author's Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE‏
670 ‎‡a Author's Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE Cohort Study‏
670 ‎‡a Author's The child with a limp: a symptom and not a diagnosis.‏
670 ‎‡a Author's The development and assessment of biological treatments for children‏
670 ‎‡a Author's Urinary biomarkers in childhood lupus nephritis‏
670 ‎‡a Author's Urinary VCAM-1 as a biomarker of lupus nephritis disease activity‏
909 ‎‡a (orcid) 0000000283717597‏ ‎‡9 1‏
919 ‎‡a unusualcauseofneonatalrespiratorydistress‏ ‎‡A An unusual cause of neonatal respiratory distress.‏ ‎‡9 1‏
919 ‎‡a addingtocomplexitycomorbidityinpaediatricrheumaticdisease‏ ‎‡A Adding to complexity: comorbidity in paediatric rheumatic disease.‏ ‎‡9 1‏
919 ‎‡a urinaryvcam1asabiomarkeroflupusnephritisdiseaseactivity‏ ‎‡A Urinary VCAM-1 as a biomarker of lupus nephritis disease activity‏ ‎‡9 1‏
919 ‎‡a urinarybiomarkersinchildhoodlupusnephritis‏ ‎‡A Urinary biomarkers in childhood lupus nephritis‏ ‎‡9 1‏
919 ‎‡a developmentandassessmentofbiologicaltreatmentsforchildren‏ ‎‡A The development and assessment of biological treatments for children‏ ‎‡9 1‏
919 ‎‡a childwithalimpasymptomandnotadiagnosis‏ ‎‡A The child with a limp: a symptom and not a diagnosis.‏ ‎‡9 1‏
919 ‎‡a predictorsofaccesstocareinjuvenilesystemiclupuserythematosusevidencefromtheukjslecohortstudy‏ ‎‡A Predictors of access to care in juvenile systemic lupus erythematosus: evidence from the UK JSLE Cohort Study‏ ‎‡9 1‏
919 ‎‡a panelsequencinglinksrarelikelydamaginggenevariantswithdistinctclinicalphenotypesandoutcomesinjuvenileonsetsle‏ ‎‡A Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE‏ ‎‡9 1‏
919 ‎‡a outcomesfollowingmycophenolatemofetilversuscyclophosphamideinductiontreatmentforproliferativejuvenileonsetlupusnephritis‏ ‎‡A Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis‏ ‎‡9 1‏
919 ‎‡a juvenileonsetsystemiclupuserythematosusjslepathophysiologicalconceptsandtreatmentoptions‏ ‎‡A Juvenile-onset systemic lupus erythematosus (jSLE) - Pathophysiological concepts and treatment options‏ ‎‡9 1‏
919 ‎‡a increasedconcentrationofplasmatnfr1andtnfr2inpaediatriclupusnephritis‏ ‎‡A Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis‏ ‎‡9 1‏
919 ‎‡a 15minuteconsultationastructuredapproachtothemanagementofhypermobilityinachild‏ ‎‡A Fifteen-minute consultation: A structured approach to the management of hypermobility in a child.‏ ‎‡9 1‏
919 ‎‡a endothelialnitricoxidesynthasepolymorphismsdonotinfluencepulmonaryarterysystolicpressureataltitude‏ ‎‡A Endothelial nitric oxide synthase polymorphisms do not influence pulmonary artery systolic pressure at altitude‏ ‎‡9 1‏
919 ‎‡a doclassicbloodbiomarkersofjsleidentifyactivelupusnephritisevidencefromtheukjslecohortstudy‏ ‎‡A Do classic blood biomarkers of JSLE identify active lupus nephritis? Evidence from the UK JSLE Cohort Study.‏ ‎‡9 1‏
919 ‎‡a diagnosisandtreatmentofchildhoodonsetsystemiclupuserythematosuseuropeanevidencebasedrecommendationsfromtheshareinitiative‏ ‎‡A Diagnosis and treatment of childhood-onset systemic lupus erythematosus (European evidence-based recommendations from the SHARE initiative)‏ ‎‡9 1‏
919 ‎‡a clinicalandlaboratoryphenotypesinjuvenileonsetsystemiclupuserythematosusacrossethnicitiesintheuk‏ ‎‡A Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK‏ ‎‡9 1‏
919 ‎‡a clinicalandlaboratorycharacteristicsinjuvenileonsetsystemiclupuserythematosusacrossagegroups‏ ‎‡A Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups‏ ‎‡9 1‏
996 ‎‡2 CAOONL|ncf10504144
996 ‎‡2 LC|no2024125693
996 ‎‡2 NUKAT|n 2012167023
996 ‎‡2 BIBSYS|90659270
996 ‎‡2 NLA|000060596056
996 ‎‡2 BIBSYS|13056152
996 ‎‡2 LC|n 95081650
996 ‎‡2 BIBSYS|1063040
996 ‎‡2 ISNI|0000000033267319
996 ‎‡2 LC|no2014014410
996 ‎‡2 BIBSYS|1036986
996 ‎‡2 ISNI|0000000036176180
996 ‎‡2 LNB|LNC10-000166678
996 ‎‡2 BIBSYS|12059016
996 ‎‡2 LC|n 2009068081
996 ‎‡2 NTA|191572942
996 ‎‡2 J9U|987007426640905171
996 ‎‡2 LC|n 88225931
996 ‎‡2 DNB|104202748X
996 ‎‡2 N6I|vtls000015202
996 ‎‡2 LC|n 79085581
996 ‎‡2 NUKAT|n 01014339
996 ‎‡2 LC|n 2014079914
996 ‎‡2 BIBSYS|7049952
996 ‎‡2 LC|n 2014079913
996 ‎‡2 NII|DA12233935
996 ‎‡2 CAOONL|ncf10154801
996 ‎‡2 CAOONL|ncf12129430
996 ‎‡2 ISNI|0000000383814554
996 ‎‡2 ISNI|0000000410192456
996 ‎‡2 NTA|068686854
996 ‎‡2 RERO|A014085032
996 ‎‡2 LC|n 96044438
996 ‎‡2 LIH|LNB:B_p_I,;=B_c_
996 ‎‡2 BIBSYS|90704415
996 ‎‡2 ISNI|0000000024128130
996 ‎‡2 NDL|00550819
996 ‎‡2 J9U|987007317374105171
996 ‎‡2 JPG|500172646
996 ‎‡2 ISNI|0000000041881087
996 ‎‡2 BIBSYS|90210316
996 ‎‡2 LC|no2005047848
996 ‎‡2 LC|no 99013748
996 ‎‡2 LC|no2010029692
996 ‎‡2 SUDOC|127352104
996 ‎‡2 LC|n 2013040331
996 ‎‡2 SUDOC|067225616
996 ‎‡2 LC|n 98086926
996 ‎‡2 ISNI|0000000383632662
996 ‎‡2 NII|DA03568783
996 ‎‡2 LC|no2009112151
996 ‎‡2 LC|no2024023034
996 ‎‡2 SUDOC|275970248
996 ‎‡2 ISNI|0000000388483782
996 ‎‡2 NII|DA17711149
996 ‎‡2 LC|no2010156371
996 ‎‡2 LC|n 82238420
996 ‎‡2 ISNI|0000000396508046
996 ‎‡2 BIBSYS|90541518
996 ‎‡2 LC|nb 98031249
996 ‎‡2 SUDOC|254380174
996 ‎‡2 LC|n 2012190785
996 ‎‡2 NTA|297704168
996 ‎‡2 LC|no2019077832
996 ‎‡2 BIBSYS|90543342
996 ‎‡2 ISNI|000000003783291X
996 ‎‡2 LC|no2014070417
996 ‎‡2 DNB|141765151
996 ‎‡2 RERO|A005814867
996 ‎‡2 J9U|987007456157705171
996 ‎‡2 LC|n 87898991
996 ‎‡2 ISNI|0000000455202128
996 ‎‡2 BNF|12444323
996 ‎‡2 ISNI|0000000080872116
996 ‎‡2 CAOONL|ncf10212759
996 ‎‡2 JPG|500016433
996 ‎‡2 LC|no2008181819
996 ‎‡2 LC|nb2004311131
996 ‎‡2 SUDOC|228872723
996 ‎‡2 PLWABN|9812624761205606
996 ‎‡2 BIBSYS|14048753
996 ‎‡2 NTA|180738267
996 ‎‡2 J9U|987007320517505171
996 ‎‡2 LC|no2023038222
996 ‎‡2 LC|nr 91033033
996 ‎‡2 LC|n 94017288
996 ‎‡2 J9U|987007322989105171
996 ‎‡2 BIBSYS|90659287
996 ‎‡2 LC|nr 90011647
996 ‎‡2 DNB|1037621190
996 ‎‡2 LC|n 81141891
996 ‎‡2 J9U|987007426085605171
996 ‎‡2 LC|n 2003122964
996 ‎‡2 DNB|100764762
996 ‎‡2 BIBSYS|90934510
996 ‎‡2 BIBSYS|90362989
996 ‎‡2 LC|n 95056624
996 ‎‡2 LC|n 80045564
996 ‎‡2 PLWABN|9810705688205606
996 ‎‡2 ISNI|000000002487909X
996 ‎‡2 LC|n 2014052151
996 ‎‡2 DNB|1053507755
996 ‎‡2 LC|n 80016677
996 ‎‡2 DNB|124941489X
996 ‎‡2 ISNI|0000000444373853
996 ‎‡2 ISNI|0000000096720184
996 ‎‡2 RERO|A022830615
996 ‎‡2 ISNI|000000007219436X
996 ‎‡2 NTA|326566325
996 ‎‡2 NKC|mub2013775221
996 ‎‡2 J9U|987007428652905171
996 ‎‡2 ISNI|0000000048081648
996 ‎‡2 ISNI|0000000067825454
996 ‎‡2 SUDOC|188442944
996 ‎‡2 ISNI|0000000107378362
996 ‎‡2 SUDOC|110604210
996 ‎‡2 LC|n 97123881
996 ‎‡2 SUDOC|269772707
996 ‎‡2 DNB|1157474187
996 ‎‡2 NTA|166203408
996 ‎‡2 LC|no 94026780
996 ‎‡2 NLA|000035078392
996 ‎‡2 ISNI|0000000035697777
996 ‎‡2 BAV|495_335483
996 ‎‡2 ISNI|0000000444374389
996 ‎‡2 CAOONL|ncf10216680
996 ‎‡2 LC|n 2007161958
996 ‎‡2 LC|no2016015577
996 ‎‡2 BNF|15010924
996 ‎‡2 LC|n 2011186886
996 ‎‡2 LC|nr 98039781
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏